Karo Pharma AB Stock
Karo Pharma AB Stock
Karo Pharma AB is currently one of the favorites of our community with 6 Buy predictions and no Sell predictions.
Based on the current price of 5.44 € the target price of 51 € shows a potential of 837.5% for Karo Pharma AB which would more than double the current price.
Pros and Cons of Karo Pharma AB in the next few years
Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
C******** o* t** e**********
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Karo Pharma AB vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Karo Pharma AB | - | - | - | - | - | - | - |
| Active Biotech AB | -2.940% | -2.941% | -10.811% | -58.750% | -25.000% | -94.190% | -97.643% |
| Medivir AB | -18.860% | -4.945% | 222.761% | -48.512% | 154.412% | -88.102% | -89.451% |
| Immunic Inc. | -5.920% | 3.364% | 43.964% | -29.229% | 85.814% | -57.409% | -94.252% |
Comments
Karooooo (NASDAQ:KARO) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Show more
Ratings data for KARO provided by MarketBeat
Karooooo (NASDAQ:KARO) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "strong-buy" rating.
Show more
Ratings data for KARO provided by MarketBeat
Karooooo Ltd. (NASDAQ: KARO) had its "outperform" rating re-affirmed by analysts at Raymond James Financial, Inc.. They now have a $60.00 price target on the stock, up previously from $58.00.
Show more
Ratings data for KARO provided by MarketBeat